Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours
Journal of Surgical Oncology · 2026-11 · 134 (6) · 814-821
DOI: 10.1002/jso.70349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 29.07.2026. Verfasst von Samuel O H Ching und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Neoplasm Recurrence, Local, Lipoma, In Situ Hybridization, Fluorescence. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LKS Faculty of Medicine.
Abstract (Originalsprache)
Background
Although MDM2 FISH test has been increasingly used to differentiate ALT and benign lipomatous tumours, its impact on clinical outcome remains underexplored. This study investigated whether routine MDM2 FISH testing on preoperative biopsy is associated with a reduction in the recurrence risk of ALT.
Methods
A total of 336 patients with MDM2 ‐verified well‐differentiated lipomatous tumours (ALT, n = 67; lipoma, n = 269) treated at a tertiary sarcoma centre were retrospectively analysed. Clinicopathological parameters, histological–molecular concordance, pre‐operative diagnostic approach and recurrence rates were compared.
Results
Compared to benign lipomatous tumours, ALT patients were older ( p = 0.002), had larger tumours (median 15.0 vs 7.0 cm, p < 0.001) and more frequently deep extremity lesions ( p < 0.001). Up to 25% of biopsy specimens of ALT exhibit purely benign morphology. ALT patients who underwent preoperative biopsy with MDM2 FISH had a lower recurrence rate than those who did not (16.2% vs 56.7%, p < 0.001). This was associated with a higher rate of extracapsular excision (97.3% vs 71.4%–77.8%, p = 0.021).
Conclusion
Routine MDM2 FISH testing on preoperative biopsy provides a definitive diagnosis of ALT, especially for lipoma‐like histology, enabling surgeons to plan extracapsular excision and thereby reducing local recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
- Orthopaedic Oncology and Limb Salvage Surgery, Department of Orthopaedic and Traumatology, Queen Mary Hospital, Hong Kong SAR, China.
ORCID-Profile: Anderson S M Leung, Raymond C H Yau, Maximus C F Yeung
Förderung
- LKS Faculty of Medicine
Zitieren
APA
Ching, S. O. H., Leung, A. S. M., Yau, R. C. H., Lam, A. Y. L., Shek, T. W. H., & Yeung, M. C. F. (2026). Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours. Journal of Surgical Oncology, 134(6), 814-821. https://doi.org/10.1002/jso.70349
Vancouver
Ching SOH, Leung ASM, Yau RCH, Lam AYL, Shek TWH, Yeung MCF. Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours. Journal of Surgical Oncology. 2026;134(6):814-821. doi:10.1002/jso.70349
BibTeX
@article{Ching2026,
author = {Ching, Samuel O H and Leung, Anderson S M and Yau, Raymond C H and Lam, Albert Y L and Shek, Tony W H and Yeung, Maximus C F},
title = {Routine MDM2 FISH Testing and Preoperative Biopsy Reduces Recurrence Rate of Atypical Lipomatous Tumours},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {134},
number = {6},
pages = {814--821},
doi = {10.1002/jso.70349}
}
EUVIMED